Riverhead Capital Management’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $98K | Buy |
8,483
+2,000
| +31% | +$23.1K | ﹤0.01% | 1329 |
|
2019
Q2 | $65K | Buy |
6,483
+1,500
| +30% | +$15K | ﹤0.01% | 1419 |
|
2019
Q1 | $64K | Hold |
4,983
| – | – | ﹤0.01% | 1411 |
|
2018
Q4 | $76K | Hold |
4,983
| – | – | ﹤0.01% | 1361 |
|
2018
Q3 | $100K | Hold |
4,983
| – | – | ﹤0.01% | 1398 |
|
2018
Q2 | $97K | Hold |
4,983
| – | – | ﹤0.01% | 1350 |
|
2018
Q1 | $100K | Buy |
4,983
+600
| +14% | +$12K | ﹤0.01% | 1336 |
|
2017
Q4 | $58K | Buy |
4,383
+1,000
| +30% | +$13.2K | ﹤0.01% | 1454 |
|
2017
Q3 | $62K | Buy |
3,383
+887
| +36% | +$16.3K | ﹤0.01% | 1411 |
|
2017
Q2 | $46K | Buy |
2,496
+1,296
| +108% | +$23.9K | ﹤0.01% | 1428 |
|
2017
Q1 | $27K | Buy |
1,200
+100
| +9% | +$2.25K | ﹤0.01% | 1420 |
|
2016
Q4 | $38K | Hold |
1,100
| – | – | ﹤0.01% | 1303 |
|
2016
Q3 | $27K | Sell |
1,100
-191,320
| -99% | -$4.7M | ﹤0.01% | 1334 |
|
2016
Q2 | $2.4M | Buy |
192,420
+188,895
| +5,359% | +$2.36M | 0.08% | 283 |
|
2016
Q1 | $83K | Buy |
+3,525
| New | +$83K | ﹤0.01% | 1349 |
|